Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Celgene’s Alkeran Extends Life in Eye-Cancer Patients in Study

Sept. 24 (Bloomberg) -- Melphalan, the active ingredient in Celgene Corp.’s Alkeran, helped patients live longer after cancer had spread from their eyes to their livers, according to a study to be presented today at the European Multidisciplinary Cancer Congress in Stockholm.

To contact the reporter on this story: Kristen Hallam in London at

To contact the editor responsible for this story: Phil Serafino at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.